NYT story renews concerns over asthma drug Singulair's psychiatric risks

As early as 2008, the FDA issued a communication advising that it would investigate a possible risk of suicidality with Singulair.

Related Keywords

New York ,United States , ,Reuters ,New York Times ,Drug Administration ,Today Merck ,